• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[儿童神经母细胞瘤的预后因素]

[Prognostic factors in neuroblastoma in children].

作者信息

Izbicki T, Laskowska-Klita T, Liebhart M, Lipińska L

机构信息

Zakład Onkologii Chirurgicznej Instytutu Matki i Dziecka w Warszawie.

出版信息

Pediatr Pol. 1995 Nov;70(11):949-53.

PMID:8677161
Abstract

The paper presents the review of prognostic factors which were investigated from the first interests of neuroblastoma, as a model for cancer biology in pediatric oncology. The authors on the basis of other authors experiences and on the own observations, as well stress the importance of basic sciences from the field of molecular biology, cytogenetics and biochemistry, leading to better understanding of the nature of neuroblastoma and to introduction of rational treatment. The stratification of neuroblastoma patients according to the known prognostic variables influenced favourably treatment results.

摘要

本文对作为儿科肿瘤学中癌症生物学模型的神经母细胞瘤的首批研究关注点——预后因素进行了综述。作者基于其他作者的经验及自身观察,强调了分子生物学、细胞遗传学和生物化学领域基础科学的重要性,这有助于更好地理解神经母细胞瘤的本质并引入合理的治疗方法。根据已知的预后变量对神经母细胞瘤患者进行分层,对治疗结果产生了有利影响。

相似文献

1
[Prognostic factors in neuroblastoma in children].[儿童神经母细胞瘤的预后因素]
Pediatr Pol. 1995 Nov;70(11):949-53.
2
Neuroblastoma: biology, prognosis, and treatment.神经母细胞瘤:生物学、预后及治疗
Pediatr Clin North Am. 2008 Feb;55(1):97-120, x. doi: 10.1016/j.pcl.2007.10.014.
3
Neuroblastoma: biology, prognosis, and treatment.神经母细胞瘤:生物学、预后和治疗。
Hematol Oncol Clin North Am. 2010 Feb;24(1):65-86. doi: 10.1016/j.hoc.2009.11.011.
4
Favorable outcome of triploid neuroblastomas: a contribution to the special oncogenesis of neuroblastoma.三倍体神经母细胞瘤的良好预后:对神经母细胞瘤特殊肿瘤发生机制的贡献
Cancer Genet Cytogenet. 2006 May;167(1):51-6. doi: 10.1016/j.cancergencyto.2005.09.001.
5
Histopathological features of pretreatment neuroblastoma are of limited clinical significance following adjustment for clinical and biological marker status.
Med Hypotheses. 2006;66(6):1078-81. doi: 10.1016/j.mehy.2005.11.039. Epub 2006 Jan 18.
6
Predicting outcomes for children with neuroblastoma.预测神经母细胞瘤患儿的预后。
Discov Med. 2010 Jul;10(50):29-36.
7
[Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].[儿童神经母细胞瘤的预后。评估方法及临床应用]
Arch Pediatr. 2004 Jul;11(7):834-42. doi: 10.1016/j.arcped.2004.02.022.
8
Neuroblastoma.神经母细胞瘤
Curr Probl Cancer. 2009 Nov-Dec;33(6):333-60. doi: 10.1016/j.currproblcancer.2009.12.001.
9
Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.增殖标志物KI-S5可区分有无MYCN扩增的晚期神经母细胞瘤的预后好坏。
Cancer. 2002 Feb 1;94(3):854-61.
10
[Prognosis and prognostic factors in oncology and oncologic surgery ].
Vnitr Lek. 2004 Jan;50(1):61-5.